Fatty liver disease (MASLD/MASH): open trials in Puerto Rico

10 open trials have a site in Puerto Rico. Registry data; only the trial team decides who can take part.

NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Manati · Mayagüez · San Juan
Registry updated 2026-11-06
NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
FDI Clinical Research, San Juan · Klinical Investigations Group, LLC, San Juan · Latin Clinical Trial Center, San Juan
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
FDI Clinical Research, San Juan · Klinical Investigations Group, LLC, San Juan · Latin Clinical Trial Center, San Juan
Registry updated 2026-10-28
NCT07631637
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Trial Treatment · Phase 2 · Regeneron Pharmaceuticals
Fundacion de Investigacion (FDI) Clinical Research, San Juan
Registry updated 2026-10-26
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Manati · Mayagüez · San Juan
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Manati · Mayagüez · San Juan
Registry updated 2026-10-23
NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Manati · Mayagüez · San Juan
Registry updated 2026-10-13
NCT05519475
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Trial Treatment · Phase 2 · Regeneron Pharmaceuticals
Isis Clinical Research Center, Guaynabo · Klinical Investigations, San Juan · Latin Clinical Trial Center, San Juan · Fundacion de Investigacion (FDI) Clinical Research, San Juan
Registry updated 2026-10-08
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Isis Clinical Research Center, Guaynabo · Klinical Investigations Group, San Juan
Registry updated 2026-10-08
NCT07221227
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Trial Treatment · Phase 3 · GlaxoSmithKline
San Juan
Registry updated 2026-07-27

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error